QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Abstract Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (33) Citing Articles via Google Scholar Google Scholar Articles by Olli-Lähdesmäki, T. Articles by Scheinin, M. Search for Related Content PubMed PubMed Citation Articles by Olli-Lähdesmäki, T. Articles by Scheinin, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 1, 1999, 19(21):9281-9288

Receptor Subtype-Induced Targeting and Subtype-Specific Internalization of Human ₂-Adrenoceptors in PC12 Cells

Tuire Olli-Lähdesmäki^{1, 2, 3}, Jaana Kallio^{1, 2}, and Mika Scheinin^{1, 2}

¹ Department of Pharmacology and Clinical Pharmacology, ² Medicity Research Laboratories, and ³ Turku Graduate School of Biomedical Sciences, University of Turku, FIN-20520 Turku, Finland

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

The three ₂-adrenergic receptor subtypes have distinct tissue distributions, desensitization properties, and, in some cell types, subtype-specific subcellular localization and trafficking properties. The subtypes also differ in their neuronal physiology. Therefore, we have investigated the localization and targeting of human ₂-adrenoceptors (₂-AR) in PC12 cells, which were transfected to express the ₂-AR subtypes A, B, and C. Inspection of the receptors by indirect immunofluorescence and confocal microscopy showed that _2A-AR were mainly targeted to the tips of the neurites, _2B-AR were evenly distributed in the plasma membrane, and _2C-AR were mostly located in an intracellular perinuclear compartment. After agonist treatment, _2A- and _2B-AR were internalized into partly overlapping populations of intracellular vesicles. Receptor subtype-specific changes in PC12 cell morphology were also discovered: expression of _2A-AR, but not of _2B- or _2C-AR, induced differentiation-like changes in cells not treated with NGF. Also _2B-AR were targeted to the tips of neurites when they were coexpressed in the same cells with _2A-AR, indicating that the targeting of receptors to the tips of neurites is a consequence of a change in PC12 cell membrane protein trafficking that the _2A-subtype induces. The marked agonist-induced internalization of _2A-AR observed in both nondifferentiated and differentiated PC12 cells contrasts with earlier results from non-neuronal cells and points out the importance of the cellular environment for receptor endocytosis and trafficking. The targeting of _2A-AR to nerve terminals in PC12 cells is in line with the putative physiological role of this receptor subtype as a presynaptic autoreceptor.

Key words: ₂-adrenoceptors; endocytosis; internalization; differentiation; PC12 cells; immunocytochemistry; targeting

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Three genes encoding adrenergic ₂-receptors (₂-AR) have been cloned (_2A/D, _2B, and _2C) in human and rodents (Kobilka et al., 1987; Regan et al., 1988; Lomasney et al., 1990; Zeng et al., 1990; Lanier et al., 1991; Chruscinski et al., 1992; Link et al., 1992). The ₂-AR are G-protein-coupled receptors and mediate effects of endogenous catecholamines and many therapeutic drugs via G-proteins to a variety of effectors, including adenylyl cyclases and ion channels (MacDonald et al., 1997). The three ₂-AR subtypes have quite similar ligand binding properties but different desensitization properties, as well as distinct subcellular and tissue distributions.

In the rodent brain, _2A-AR expression is widely distributed in noradrenergic projection areas but is also abundant in the locus ceruleus and other noradrenergic nuclei, in line with the presynaptic autoreceptor function of this subtype (Nicholas et al., 1993; Scheinin et al., 1994; Talley et al., 1996; Wang et al., 1996; MacDonald et al., 1997). _2A-AR are also present in the medulla and spinal cord in areas involved in control of autonomic functions and nociception (Rosin et al., 1993; Nicholas et al., 1996). In studies on genetically engineered mice, the _2A-AR has been shown to be crucial in the central hypotensive (MacMillan et al., 1996), sedative (Lakhlani et al., 1997; Sallinen et al., 1997; Stone et al., 1997), and analgesic effects (Lakhlani et al., 1997; Stone et al., 1997) of ₂-AR agonists. In the CNS, _2B-AR are only expressed in the thalamus (McCune et al., 1993; Nicholas et al., 1993; Scheinin et al., 1994; Winzer-Serhan and Leslie, 1997), but they are present in many tissues outside the CNS, and their physiological significance has been clearly established in the regulation of peripheral blood vessel tone (Link et al., 1996). _2C-AR are mainly localized in the basal ganglia, olfactory tubercle, hippocampus, and cerebral cortex (Nicholas et al., 1996; Rosin et al., 1996), and behavioral studies with transgenic mice suggest that _2C-ARs may serve important functions in sensorimotor integration (Sallinen et al., 1998a,b).

Differences in receptor regulation have been described for the three ₂-AR subtypes. Long-term desensitization has been observed in fibroblast cell lines for all ₂-AR subtypes, but the extent of desensitization is greater for the _2A- and _2B-AR subtypes compared with _2C-AR (Eason and Liggett, 1992, 1993). The subtypes also show distinct subcellular localization and targeting patterns in some non-neuronal cell types (von Zastrow et al., 1993; Daunt et al., 1997). Because the ₂-AR have fundamental functions in neuronal physiology and pharmacology, we decided to examine their subcellular distributions and the effects of agonist activation on their trafficking within a neuronal cell type. As a model, we used the rat pheochromocytoma cell line PC12, which has many similarities with postganglionic sympathetic neurons (Lee et al., 1977, 1980), especially after differentiation (Greene and Tischler, 1976). Our hypothesis was that the _2A-AR subtype would be specifically targeted to nerve terminals, as expected for an autoreceptor, and that the localization of _2A-AR would thus differ from the other two ₂-AR subtypes.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Antibodies and chemicals. Rabbit polyclonal antisera against the C termini of _2A- and _2C-AR (Daunt et al., 1997) were kindly provided by Dr. B. K. Kobilka (Stanford University, Stanford, CA). A monoclonal antibody against _2B-AR (Liitti et al., 1997) was kindly provided by S. Liitti and H. Frang (Center for Biotechnology, Turku, Finland). Hygromycin B was from Boehringer Mannheim (Indianapolis, IN), FITC-conjugated sheep anti-mouse IgG, ()norepinephrine, and the neomycin analog G418 were from Sigma (St. Louis, MO), and the FITC-conjugated sheep anti-rabbit IgG was from Silenius Laboratories (Victoria, Australia). The anti-neurofilament (NF) 160 kDa antibody and the radioligand [³H]RX821002 [2-(2-methoxy-1,4-benzodioxan-2-yl)-2-imidazoline] were from Amersham Pharmacia Biotech (Buckinghamshire, UK). RX821002 was from Research Biochemicals (Natick, MA), atipamezole and dexmedetomidine were gifts from Orion Pharma (Turku, Finland), and rauwolscine was from Carl Roth KG (Karlsruhe, Germany). Cell culture reagents were from Life Technologies (Gaithersburg, MD) unless mentioned otherwise. Nerve growth factor (NGF) was from Promega (Madison, WI). Other chemicals were of analytical or reagent grade and were purchased from commercial suppliers.

Cell culture. PC12 cells (American Type Culture Collection, CRL 1721) were grown in collagen-coated [1% Vitrogen 100 (Collagen Corporation, Fremont, CA) and 0.1% BSA] 25 and 75 cm² cell culture flasks (Falcon; Becton Dickinson, Meylan, France) in DMEM supplemented with 2.5% heat-inactivated fetal bovine serum, 12.5% heat-inactivated horse serum (HS) (Kraeber GmbH & Co., Hamburg, Germany), 292 mg/l L-glutamine, 100 U/ml penicillin, 50 µg/ml streptomycin, 1 mM sodium pyruvate, and 20 mM NaHCO₃, in water-saturated 5% CO₂ at 37°C. Two-thirds of the growth medium was changed every third day, and cells were replated every 5-6 d. Passages 4-20 of stable transfected clones were used. Before plating the cells onto glass coverslips, the cells were trypsinized, because harvesting with a rubber policeman altered the microscopic morphology and slowed the differentiation of PC12 cells. A rubber policeman was used for harvesting cells for radioligand binding studies. Differentiation was induced by incubating cells with 50-100 nM 2.5S NGF in DMEM plus 1-3% HS on collagen or 0.1 mg/ml poly-L-lysine-coated (Sigma) glass coverslips or cell culture plastics. Non-transfected PC12 cells did not express endogenous ₂-AR as evidenced by immunocytochemistry and radioligand binding.

Stable expression of human ₂-ARs. The cDNAs encoding human ₂-AR subtypes were a gift from Dr. R. J. Lefkowitz (Duke University, Durham, NC) (Kobilka et al., 1987; Regan et al., 1988; Lomasney et al., 1990). The construction of the pMAMneo- and pREP-based (Clontech, Palo Alto, CA) expression vectors for stable or semistable expression, respectively, of human _2A-, _2B-, and _2C-AR (Marjamäki et al., 1992, 1993) was performed with standard methods. The PC12 cells were plated onto collagen-coated tissue culture dishes and transfected 24 hr later by the calcium phosphate precipitation method (Chen and Okayama, 1987, 1988). The selection of stable or semistable transfectants was performed with 500 µg/ml the neomycin analog G418 (Greene et al., 1991) or Hygromycin B, respectively. Resultant clones were screened for _2A-, _2B-, and _2C-AR expression by immunofluorescent staining and radioligand binding. Only weak immunostaining was observed in clones expressing <500-800 fmol ₂-AR/mg protein. Stable clones expressing receptor densities of 1.0-2.5 pmol/mg total cellular protein were chosen for further studies. The double transfections for colocalization studies were done by pREP-mediated transfection of stable PC12_2A cells with _2B-cDNA and of stable PC12_2B cells with _2A-cDNA. The coexpression of _2A- and _2B-AR was detected by double-staining with subtype-specific antibodies.

Preparation of cell homogenates and saturation binding assays. Cells were harvested into chilled PBS, pelleted, and frozen at 70°C. Saturation binding assays with cell homogenates and [³H]RX821002 were performed in K⁺-phosphate buffer as described previously (Halme et al., 1995).

Receptor activation. Cells were plated on collagen- or poly-L-lysine-coated glass coverslips at 1-2 × 10⁴ cells/cm². After 4-6 d of culture, the differentiated and nondifferentiated cells were treated with serum-free DMEM containing 10 µM norepinephrine or 10 nM dexmedetomidine for 30 min at 37°C, in 5% CO₂. The medium was then aspirated, and the cells were rinsed once with 4°C PBS and fixed.

Immunocytochemistry. Cultures of PC12 cells on glass coverslips were fixed for 20 min at room temperature or for 5 min at 4°C and 15 min at room temperature (for agonist-treated cells) with 4% paraformaldehyde in PBS. After fixation, the cells were either stained immediately or stored in PBS at 4°C for later staining. The staining was performed at room temperature. Nonspecific binding was blocked by incubating the cells for 45 min with blocking buffer containing 0.2% Nonidet P-40 (Calbiochem, La Jolla, CA) as permeabilizing agent (not added in all experiments) and 5% non-fat dry milk in 50 mM Tris-HCl, pH 7.6. The cells were incubated for 45 min with primary antibodies or antisera diluted in the same buffer (anti-_2A and -_2C, 1:500; anti-_2B, 10 µg/ml, anti-NF, 1:100). After incubation, the cells were rinsed three times with PBS, followed by 5 min blocking and incubation with secondary antibody diluted 1:500 [FITC-conjugated anti-mouse IgG and FITC- or tetramethylrhodamine isothiocyanate (TRITC)-conjugated anti-rabbit IgG] in the blocking buffer (for 30 min) in darkness. After rinsing three times with PBS, the coverslips were mounted for fluorescent microscopy onto a drop of anti-fade mounting medium containing 50% glycerol, 100 mg/ml 1,4-diazabicyclo-[2.2.2.]octane (Sigma) and 0.05% sodium azide in PBS on microscope slides. As negative controls, transfected PC12 cells were stained in a similar manner but without the primary antibody, or nontransfected PC12 cells were stained as above. Stained cells were not observed under these conditions. The specificity of the receptor antibodies was verified by cross-staining the ₂-AR subtypes in PC12 cells. Single- and double-labeled immunofluorescent microscopy was performed using a conventional fluorescence microscope (Olympus BHS, Olympus 100×/D Plan Apo, 100 UV, 1.30 objective; Olympus Opticals, Tokyo, Japan) and a laser scanning confocal microscope (Leica DM RXA, 100×/1.4 oil ICT:D objective; Leica, Nussloch, Germany).

Immunocytochemistry of cells expressing both _2A- and _2B-AR was performed using simultaneously the above described rabbit polyclonal antibody against _2A-AR and the mouse monoclonal antibody against _2B-AR. Anti-rabbit TRITC and anti-mouse FITC were used for visualization.

Electron microscopy. PC12 cells were cultured and fixed as described above and post-fixed with potassium ferrocyanide-osmium fixative (Karnovsky, 1971). The cells were embedded in epoxy-resin (Glycidether 100; Merck, Darmstadt, Germany) and then sectioned for electron microscopy. Ultrathin sections were stained with 12.5% uranyl acetate (Stempak and Ward, 1964) and 0.25% lead citrate (Venable and Coggeshall, 1965) and examined in a Jeol JEM-100SX electron microscope (Jeol, Akishima, Japan).

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

_2A-AR are distinctly targeted in differentiating PC12 cells

During NGF-induced differentiation, neurites were seen as soon as after 2 d treatment in _2A-, _2B-, and _2C-AR-transfected PC12 cells. Growth cones were seen on plasma membranes of transfected and untransfected PC12 cells as soon as after the first day of NGF treatment. During differentiation, the cells flattened out, and there was an increase in the number of growth cones and in the number and length of neurites.

PC12 cells transfected with the _2A-AR plasmid acquired an altered phenotype also without NGF treatment (see below). In PC12_2A cells not treated with NGF, _2A-AR staining was observed on plasma membranes all over the cell (Fig. 1a). Abundant _2A-AR staining was present in the filopodia and the growth cones of PC12_2A cells, which remained brightly stained during the entire course of differentiation. After 5-6 d of NGF-induced differentiation and neurite outgrowth, the distal segments of the neurites stained more brightly compared with the weaker staining of the plasma membrane over the cell body, suggesting that the receptors are clustered to the tips of neurites (Fig. 1b).

View larger version (62K): [in this window] [in a new window]   Figure 1.   Scanning confocal images of nondifferentiated (a, c, e) (100×) and differentiated (b, d, f) (50×) PC12 cells expressing human 2-AR subtypes, immunostained with 2-AR subtype-specific antibodies. The images are summations of 12 midsections of permeabilized cells. In nondifferentiated PC122A cells, 2A-AR staining is seen on plasma membranes all over the cells, and clusters of 2A-AR are seen on filopodia and growth cones (a, arrow). After NGF-treatment, clustering of the 2A-AR staining to the tips (arrows) of the neural extensions is seen (b). 2B-AR staining is localized evenly on plasma membranes (arrows) in nondifferentiated (c) and differentiated (d) cells, and 2C-AR staining is localized mainly intracellularly (arrows) before (e) and after (f) differentiation.

_2B-AR were localized evenly on plasma membranes in undifferentiated (Fig. 1c) and differentiated (Fig. 1d) PC12 cells, and there was no enrichment of _2B-AR staining in growth cones or neurites during NGF-induced differentiation (Fig. 1d). _2C-AR staining was found mainly intracellularly and perinuclearly in undifferentiated (Fig. 1e) and differentiated (Fig. 1f) PC12 cells, and the plasma membrane staining was weaker compared with the _2A- and _2B-AR subtypes.

_2A- and _2B-AR internalize after agonist activation

Receptor activation was induced with the ₂-AR agonists norepinephrine (10 µM, 30 min) and dexmedetomidine (10 nM, 30 min), in both undifferentiated and differentiated cells. Clear intracellular punctate staining (Fig. 2a) could be seen in agonist-treated PC12_2A cells; this was not observed in cells not treated with ₂-AR agonists. These clustered immunoreactive puncta were considered to represent internalized receptors in some intracellular compartment of the cells, because no punctate staining was observed in nonpermeabilized cells. Also, confocal microscopy showed clusters of immunoreactive material in the midsections of the cells, confirming their intracellular nature. The growth cones and the filopodia of PC12_2A cells remained brightly stained after agonist treatment (Fig. 2a,b).

View larger version (62K): [in this window] [in a new window]   Figure 2.   Scanning confocal images of nondifferentiated (a, c, e) (100×) and differentiated (b, d, f) (50×) PC12 cells expressing human 2-AR subtypes after norepinephrine (10 µM) treatment. The images are summations of 12 midsections of permeabilized cells. The cells were immunostained with 2-AR subtype-specific antibodies. Similar receptor trafficking is observed in nondifferentiated and differentiated cells: 2A- and 2B-AR are internalized into intracellular vesicles (arrowheads) after norepinephrine-induced receptor activation (a-d), although the growth cones and neural tips of PC122A cells remain brightly stained (a, b, arrows). The localization of 2C-AR is not changed by agonist treatment (e, f). More numerous and brighter intracellular vesicles are seen in PC122B cells (c, d) than in PC122A cells (a, b), suggesting that internalization of 2B-AR is stronger than that of 2A-AR.

The agonist treatment also induced internalization of _2B-AR, which was stronger than that of _2A-AR; in confocal microscopy, most of the receptor staining of agonist-treated PC12_2B cells was observed intracellularly, and plasma membrane staining was almost invisible (Fig. 2c). No change was observed in the localization of agonist-activated _2C-AR compared with cells not treated with ₂-AR agonists (Fig. 2e). There was no difference in the agonist-induced internalization in nondifferentiated versus differentiated PC12_2B and PC12_2C cells (Fig. 2d,f). All differentiation and receptor activation experiments have been repeated with 2-4 independent clones of the three different human ₂-AR subtypes, 3-30 times per clone.

_2A-and _2B-AR internalize into partly separate intracellular vesicles

Immunostaining and scanning confocal microscopy of agonist-treated double-transfected PC12_2A-B cells showed that _2A- and _2B-AR are colocalized in plasma membrane and neural tips before agonist treatment (Fig. 3a,c). After agonist treatment, clear internalized vesicles of both _2A- and _2B-AR were seen in 0.16 µm slice thin images (Fig. 3b,d). Intracellular staining of vesicles containing these two internalized receptor subtypes was partly overlapping (yellow in confocal images) and partly distinct (red and green, respectively), suggesting that _2A- and _2B-AR would be internalized into partly distinct populations of intracellular vesicles. However, both receptor subtypes remained in neural tips after agonist treatment (Fig. 3b,d).

View larger version (32K): [in this window] [in a new window]   Figure 3.   Scanning confocal images of PC122A-B cells coexpressing 2A- and 2B-AR immunostained with subtype-specific rabbit anti-2A antiserum-anti-rabbit TRITC (red) and mouse anti-2B antibody-anti-mouse FITC (green). Images (a, b, 100×; c, d, 50×) represent single 0.16 µm thin midsections from scanned cells. Overlapping 2A- and 2B-AR staining (yellow) is seen on the plasma membrane and in the tips (arrows) of neural extensions (a-d), indicating colocalization of 2A- and 2B-AR in these locations. After agonist treatment (b, d), 2A- and 2B-AR are internalized into partly separate (separate red and green puncta) (arrowheads) and partly shared (yellow puncta) intracellular vesicles. The tips of the neurites remain yellow (b, d) (arrows), indicating that the two subtypes are still colocalized and not redistributed by agonist treatment in these parts of the cells.

Expression of _2A-AR induces differentiation of PC12 cells

The culture of PC12 cells was performed according to Greene and Tischler (1976), using collagen-coated Falcon cell culture flasks after selection of the transfected clones. The morphology of the cells was not changed during 3-20 passages when the cells were replated every 5-6 d and divided 1:4-6.

Receptor subtype-specific changes in PC12 cell shape and growth type were discovered after the selection of the transfected clones. The shape of PC12_2A cells was clearly different from clones expressing _2B- and _2C-AR. The PC12_2A cells flattened out, and their cytoplasm was thinner compared with the other clones. The cells tended to differentiate without NGF, and they developed growth cones and short neurites (Fig. 4b). The extent of this tendency to differentiate was proportional to the receptor expression level of individual _2A-AR-expressing clones (n = 5) (data not shown). To examine the possibility that activation of _2A-AR by endogenous norepinephrine produced by the PC12_2A cells would induce this morphological change, we cultured the cells in medium supplemented with selected ₂-AR antagonists to block _2A-AR. Treatment of PC12_2A cells with the ₂-AR antagonists atipamezole, rauwolscine, or RX821002 (5 µM) did not influence the tendency of PC12_2A cells to undergo morphological differentiation. The shape of PC12_2B and PC12_2C cells (Fig. 4c,d) remained similar to that of untransfected PC12 cells. Both untransfected and transfected PC12 cells were successfully stained with an anti-neurofilament antibody to confirm the preserved neuronal phenotype of the cells (data not shown).

View larger version (135K): [in this window] [in a new window]   Figure 4.   Phase-contrast microscopic images (10×) of living nontransfected (a) and 2-AR expressing (b-f) PC12 cells in collagen-coated Falcon cell culture flasks. Compared with nontransfected PC12 cells (a), the 2A-AR expressing cells (b) showed morphological changes under normal culturing conditions during the first few (1-3) passages after transfection; the PC122A cells flattened out and their cytoplasm was thinner compared with clones expressing other 2-AR subtypes, and they developed growth cones and short neurites without NGF-treatment (b). The morphology of PC122B and PC122C cells remained similar to the nontransfected cells (c, d). The different morphology of PC122A cells (2A-B) did not change by the coexpression of 2B-AR (e), but expression of 2A-AR in PC122B (2B-A) cells induced similar morphological changes (f) as after transfection of PC12 cells with 2A-AR alone (b). Culture from passage 3 to passage 20 did not change the acquired morphology of the clones.

The _2A -AR-induced differentiation allows targeting of _2A- and _2B-AR to the tips of neural extensions of PC12 cells

To explore whether the targeting of _2A-AR to the tips of neural extensions of differentiated PC12 cells would be secondary to the changes induced by expression of the _2A-subtype, cotransfection studies were performed. Expression of _2A-AR in PC12_2B cells (PC12_2B-A cells) induced similar differentiation-like morphological changes, as seen after transfection with _2A-AR alone. The morphological changes were obvious as soon as during the first passage (Fig. 4f). Expression of _2B-AR in PC12_2A cells (PC12_2A-B cells) did not change the _2A-induced differentiated phenotype of the cells (Fig. 4e). Immunostaining of cotransfected PC12_2A-B and PC12_2B-A cells, visualized by conventional fluorescent microscopy and scanning confocal microscopy, showed overlapping _2A- and _2B-specific immunoreactivity in the tips of neural extensions (Figs. 3, 5c-f). This indicates that expression of _2A-AR permits targeting of _2B-AR also to neurite tips in PC12 cells. The different distribution of _2B-AR in PC12_2B cells differentiated with NGF and in PC12_2A-B/_2B-A cells expressing both _2A- and _2B-AR is illustrated in Figure 5.

View larger version (68K): [in this window] [in a new window]   Figure 5.   Scanning confocal images (50-100×) of non-NGF-differentiated (a, c, d, e, f) and NGF-differentiated (b) PC12 cells expressing human 2B-AR alone (a, b) and coexpressing human 2A- and 2B-AR (c-f), immunostained with monoclonal anti-human 2B-AR antibody (a, b, c, e) and polyclonal 2A-AR antiserum (d, f). The images are summations of 12 midsections of permeabilized cells. When expressed alone, 2B-AR are localized evenly on plasma membranes in nondifferentiated (a) and differentiated (b) PC122B cells, and no concentration of staining into the tips of neural processes is seen (arrows). When 2B-AR are expressed in PC122A cells (PC122A-B), the 2B-AR are targeted into the growth cones and neural processes (c) (arrows), and overlapping staining can be seen with 2A-AR (d). The expression of 2A-AR in PC122B cells (PC122B-A) induced differentiation-like morphological changes and similar targeting of 2B-AR (e) and 2A-AR (f) into the tips (arrows) of developed neural processes.

To examine the possibility that extensive membrane ruffling in neural extensions of PC12 cells would create the image of receptor concentration, we prepared electron microscopic samples of PC12 cell neural extensions. Prominent membrane ruffling was seen in many growth cones and shorter extensions (average length in slice, 5.8 µm), but in longer extensions (average length in slice, 18.8 µm), similar to the neurite tips in which receptor concentration was observed, no apparent membrane ruffling was seen, indicating that the concentration of ₂-AR-specific staining in the tips of neural extensions was not an artifact induced by membrane ruffling.

	DISCUSSION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

The aim of this study was to examine the subcellular distribution of human ₂-AR subtypes in neuronal cells, because ₂-ARs are widely distributed in the brain and spinal cord and in peripheral sympathetic nerve cells and because the elucidation of their targeting and trafficking properties might provide important information about their function and regulation (Nicholas et al., 1996; Koenig and Edwardson, 1997). As a neuronal cell type, we used PC12 cells, which are derived from a rat pheochromocytoma tumor (Greene and Tischler, 1976) and are often used as a model of postganglionic sympathetic neurons (Lee et al., 1977; Youdim et al., 1986).

Receptor subtype-specific differences were demonstrated in the subcellular localization of transfected human ₂-AR subtypes in differentiating neuronal cells; _2A-AR were distinctly targeted to the tips of the neural extensions, and both _2A- and _2B-AR were internalized after receptor activation. The results also show that expression of _2A-AR induced differentiation-like changes in PC12 cell morphology and growth type, which also permitted targeting of _2B-AR to the tips of the neural extensions.

The predominant ₂-AR subtype in the brain and spinal cord is the _2A-AR (MacDonald et al., 1997; Lawhead et al., 1992; Nicholas et al., 1993), which mediates the hypnotic, sedative, sympatholytic, as well as analgesic, effects of ₂-AR activation (MacMillan et al., 1996; Lakhlani et al., 1997; Sallinen et al., 1997; Stone et al., 1997). In major noradrenergic nuclei of the rat brain, _2A-mRNA is present in the cell bodies, which suggests that _2A-AR are presynaptic autoreceptors, mediating inhibition of synaptic norepinephrine release (Scheinin et al., 1994). The _2A-AR immunoreactivity in the brain is found on presynaptic axons and also in perikarya in which it is localized within intracellular structures involved in synthesis and trafficking of receptors (Milner et al., 1999). The CNS functions of _2B-AR are still unknown (MacDonald et al., 1997) and _2C-AR are thought to have modulatory effects on several different brain functions, e.g., sensorimotor integration (MacDonald et al., 1997; Sallinen et al., 1997, 1998a,b).

This study shows that, during PC12 cell differentiation, _2A-AR are targeted to the developing neurites, concentrating into their tips, directed by functional changes induced by this receptor. This indicates that _2A-AR have properties that enable the intracellular machinery of the cell to induce differentiation and to allow membrane-bound receptors to be transported along the neurites to the site of autoreceptor action. The targeting of _2A-AR to the tips of the neurites during neuronal differentiation resembles that of the G-protein isoform G_o, which mediates ₂-adrenergic inhibition of neurotransmitter release. Also, G_o-proteins are targeted to the growth cones, filopodia, and the tips of neurites during NGF-induced differentiation of PC12 cells (Zubiaur and Neer, 1993). On the contrary, in Madin-Darby canine kidney (MDCK) cells, transfected _2A-AR have been shown to be targeted to the basolateral surface, which is thought to correspond to the somatodendritic parts of neuronal cells (Keefer et al., 1994). It was, however, recently shown that trafficking of _2A-AR in neurons could be predicted based on the trafficking of the endogenous apically expressed _2A-AR in MDCK cells (Okusa et al., 1994). All ₂-AR subtypes were localized in the cell bodies and along neurites when transfected into cultured primary spinal cord neurons (Wozniak and Limbird, 1998). In our study, using a model of peripheral postganglionic neurons, the distinct targeting of ₂-AR subtypes in PC12 cells was found to be secondary to the functional changes induced by _2A-AR in these cells. The distinct targeting of _2A-AR gives evidence of the neuronal autoreceptor-like character of human _2A-AR in peripheral sympathetic neurons, because _2B-AR were evenly distributed in the plasma membrane and _2C-AR were mainly intracellular when expressed in PC12 cells without _2A-AR. This is in line with previous studies on non-neuronal cell types; in nonpolarized fibroblasts (von Zastrow et al., 1993; Daunt et al., 1997) and in polarized epithelial cells (Wozniak and Limbird, 1996), _2A- and _2B-AR resided primarily in the plasma membrane, whereas a large proportion of _2C-AR was found in the endoplasmic reticulum and in cis/medial Golgi.

The mechanisms mediating targeting of receptors and other membrane-associated proteins in nerve cells are not fully understood. Mutagenesis studies of _2A-AR have shown that the direct delivery of this receptor to the basolateral membrane in polarized MDCK cells most likely involves transmembranous structures and that the third cytoplasmic loop of the receptor probably contains structural elements important for the stabilization of the receptor in its subcellular locus (Keefer et al., 1994; Saunders et al., 1998). Synaptic proteins, e.g., postsynaptic density-95/synapse-associated protein 90 (PSD-95/SAP90), participate in targeting of many membrane-associated neuronal proteins (Kim et al., 1995; Kornau et al., 1995). The roles of these and other proteins in targeting the adrenergic ₂-receptors remain to be demonstrated.

Subtype-specific desensitization properties of ₂-AR have been reported. In Chinese hamster ovary and COS cells, both _2A- and _2B-AR are effectively desensitized by phosphorylation, whereas _2C-AR are not (Eason and Liggett 1992, 1993; Kurose and Lefkowitz, 1994). In a study on transfected human embryonic kidney 293 (HEK-293) cells, extensive agonist-induced internalization of mouse _2B-AR was observed, whereas very limited internalization of mouse _2A-AR was detected by ELISA but not by immunofluorescent methods (Daunt et al., 1997). This suggested that _2A-AR internalization may occur by a nonendosomal mechanism, different from _2B-AR internalization. In this study, we could visualize extensive internalization of human _2A-AR after agonist-induced activation of the receptors in both nondifferentiated and differentiated PC12 cells. This emphasizes the importance of the cellular environment for receptor function. The neuronal, adrenergic PC12 cells contain an as yet unknown machinery that makes the rapid agonist-induced internalization of _2A-AR possible. Internalization of this ₂-AR subtype may subserve some important regulatory function in neuronal cells not observed in some other types of cells. The extensive internalization of _2B-AR observed in this study has also been reported in other cell types (Daunt et al., 1997). No _2C-AR internalization was visualized in this study, because this receptor was mainly localized intracellularly already at baseline, and a further reduction in the small plasma membrane _2C-AR population would not have been detectable.

A recent study of D1 and D2 dopamine receptors coexpressed in HEK-293 cells showed receptor subtype-specific endocytosis by distinct mechanisms (Vickery and von Zastrow, 1999). When coexpressing _2A- and _2B-AR in the same PC12 cells, the receptor subtypes were seen in partly separate populations of intracellular vesicles (Fig. 3), indicating partly distinct endocytotic mechanisms. The intracellular vesicles containing ₂-AR subtypes could also be in different stages of the endocytotic cycle, suggesting that the kinetics of internalization would differ between the ₂-subtypes.

In the present study, PC12 cells acquired morphological features dependent on the transfected ₂-AR subtype; especially expression of the _2A-AR subtype clearly altered their morphology. The human _2A-AR is known to control actin polymerization and focal adhesion assembly in preadipocytes but only after agonist stimulation of overexpressed _2A-AR or by constitutively active _2A-AR (Betuing et al., 1996). Overexpression of Ca²⁺/calmodulin-dependent protein kinase II has also resulted in altered PC12 cell growth and morphology (Masse and Kelly, 1997). Morphological changes of PC12 cells will not, however, happen along with expression of any protein at densities above physiological levels because, in this study, only PC12_2A cells presented marked morphological differentiation-like changes, despite similar receptor densities. The morphological changes induced by _2A-AR expression were not inhibited by ₂-AR antagonist treatment, which indicates that the change is not induced by _2A-AR activation by norepinephrine produced and released by the cells. The morphological changes were seen in all PC12_2A clones expressing _2A-AR above the level of 500 fmol/mg protein, and the changes were more pronounced in cell clones with higher receptor densities. Therefore, it seems unlikely that our results were attributable to selecting G418-resistant PC12 clones that simply were more efficient in differentiation. The differentiating effect of _2A-AR could be repeated with the expression of _2A-AR in PC12_2B cells; the morphology of these PC12_2B-A cells became similar to that of PC12_2A cells. The mechanism of subtype-specific morphological change of PC12_2A cells remains unclear, but constitutive activity of the transfected _2A-AR is one possible mechanism mediating this effect.

The human _2A-AR was described to induce membrane ruffling of preadipocytes (Betuing et al., 1996). To avoid misinterpretations of receptor localization induced by immunocytochemical staining of the ruffled plasma membrane, electron microscopy of PC12_2A-_B and PC12_2B-_A cells was performed. Membrane ruffling was detected in growth cones and short neural extensions but not in longer extensions. The concentration of _2A-specific immunocytochemical staining seen in the long neural extensions is therefore not induced by membrane ruffling. Also, the concentrated staining of the neural tips in thin slices of confocal images in Figure 3 confirms this observation.

The specific targeting of _2A-AR to developing nerve terminals indicates that its localization is appropriate for an autoreceptor. Extensive internalization of _2A-AR was observed in nondifferentiated and differentiated sympathetic neuron-like cells, which indicated different sequestration of this receptor in PC12 cells compared with some non-neuronal cell types. The significance of this difference for functional _2A-AR desensitization is still unknown. These present results point out the importance of the cellular environment for receptor endocytosis and trafficking.

	FOOTNOTES

Received June 11, 1999; revised Aug. 6, 1999; accepted Aug. 11, 1999.

This work was supported by the Academy of Finland, Turku Graduate School of Biomedical Sciences, Turku University Hospital, and the Technology Development Centre of Finland. We thank Brian Kobilka for antibodies, Thomas Bymark for expert assistance with confocal microscopy, Anne Marjamäki and Katariina Pohjanoksa for help with the expression constructs of human ₂-AR, Lauri Pelliniemi for guidance in electron microscopy, Eero Castrén for valuable comments regarding this manuscript, and Anna-Mari Pekuri, Annele Sainio, and Ulla Uoti for technical assistance.

Correspondence should be addressed to Mika Scheinin, Department of Pharmacology and Clinical Pharmacology, University of Turku, FIN-20520 Turku, Finland.

	REFERENCES

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

• Betuing S, Daviaud D, Valet P, Bouloumie A, Lafontan M, Saulnier-Blache JS (1996) ₂-Adrenoceptor stimulation promotes actin polymerization and focal adhesion in 3T3F442A and BFC-1 preadipocytes. Endocrinology 137:5220-5229[Abstract].
• Chen CA, Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752[Abstract/Free Full Text].
• Chen CA, Okayama H (1988) Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6:632-638[ISI][Medline].
• Chruscinski AJ, Link RE, Daunt DA, Barsh GS, Kobilka BK (1992) Cloning and expression of the mouse homolog of the human 2-C2 adrenergic receptor. Biochem Biophys Res Commun 186:1280-1287[ISI][Medline].
• Daunt AD, Hurt C, Hein L, Kallio J, Feng F, Kobilka BK (1997) Subtype-specific intracellular trafficking of 2-adrenergic receptors. Mol Pharmacol 51:711-720[Abstract/Free Full Text].
• Eason MG, Liggett SB (1992) Subtype-selective desensitization of ₂-adrenergic receptors. J Biol Chem 267:25473-25479[Abstract/Free Full Text].
• Eason MG, Liggett SB (1993) Functional ₂-adrenergic receptor-Gs coupling undergoes agonist-promoted desensitization in a subtype-selective manner. Biochem Biophys Res Commun 193:318-323[ISI][Medline].
• Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428[Abstract/Free Full Text].
• Greene LA, Sobeih MM, Teng KK (1991) Methodologies for the culture and experimental use of the PC12 rat pheochromocytoma cell line. In: Culturing nerve cells (Banker G, Goslin K, eds), pp 207-226. Cambridge, MA: MIT.
• Halme M, Sjöholm B, Savola J-M, Scheinin M (1995) Recombinant human 2-adrenoceptor subtypes: comparison of [³H]rauwolscine, [³H]atipamezole and [³H]RX821002 as radioligands. Biochim Biophys Acta 1266:207-214[Medline].
• Karnovsky MJ (1971) Use of ferrocyanide-reduced osmium tetroxide in electron microscopy. In: Proceedings of the 11th Annual Meeting of the American Society of Cell Biology.
• Keefer JR, Kennedy ME, Limbird LE (1994) Unique structural features important for stabilization versus polarization of the 2A-adrenergic receptor on the basolateral membrane of Madin-Darby canine kidney cells. J Biol Chem 269:16425-16433[Abstract/Free Full Text].
• Kim E, Niethammer M, Rothschild A, Jan YN, Sheng M (1995) Clustering of Shaker-type K⁺ channels by interaction with a family of membrane-associated guanylate kinases. Nature 378:85-88[Medline].
• Kobilka BK, Matsui H, Kobilka TS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ, Regan JW (1987) Cloning, sequencing, and expression of the gene coding for the human platelet 2-adrenergic receptor. Science 238:650-656[Abstract/Free Full Text].
• Koenig JA, Edwardson JM (1997) Endocytosis and recycling of G protein-coupled receptors. Trends Pharmacol Sci 18:276-287[Medline].
• Kornau HC, Schenker LT, Kennedy MB, Seeburg PH (1995) Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269:1737-1740[Abstract/Free Full Text].
• Kurose H, Lefkowitz RJ (1994) Differential desensitization and phosphorylation of three cloned and transfected 2-adrenergic receptor subtypes. J Biol Chem 269:10093-10099[Abstract/Free Full Text].
• Lakhlani PP, MacMillan LB, Guo TZ, McCool BA, Lovinger DM, Maze M, Limbird LE (1997) Substitution of a mutant _2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci USA 94:9950-9955[Abstract/Free Full Text].
• Lanier SM, Downing S, Duzic E, Homcy CJ (1991) Isolation of rat genomic clones encoding subtypes of the 2-adrenergic receptor. J Biol Chem 266:10470-10478[Abstract/Free Full Text].
• Lawhead RG, Blaxall HS, Bylund DB (1992) 2A is the predominant 2 adrenergic receptor subtype in human spinal cord. Anesthesiology 77:983-991[ISI][Medline].
• Lee V, Shelanski ML, Greene LA (1977) Specific neural and adrenal medullary antigens detected by antisera to clonal PC12 and pheochromocytoma cells. Proc Natl Acad Sci USA 74:5021-5025[Abstract/Free Full Text].
• Lee VM, Shelanski ML, Greene LA (1980) Characterization of antisera raised against cultured rat sympathetic neurons. J Neurosci 5:2239-2245.
• Liitti S, Närvä H, Marjamäki A, Hellman J, Kallio J, Jalkanen M, Matikainen MT (1997) Subtype specific recognition of human alpha2C2 adrenergic receptor using monoclonal antibodies against the third intracellular loop. Biochem Biophys Res Commun 233:166-172[ISI][Medline].
• Link R, Daunt D, Barsh G, Chruscinski A, Kobilka BK (1992) Cloning of two mouse genes encoding ₂-adrenergic receptor subtypes and identification of a single amino acid in the mouse ₂C10 homolog responsible for an interspecies variation in antagonist binding. Mol Pharmacol 42:16-27[Abstract].
• Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, Barsh GS, Kobilka BK (1996) Cardiovascular regulation in mice lacking 2-adrenergic receptor subtypes B and C. Science 273:803-805[Abstract].
• Lomasney JW, Lorenz W, Allen LF, King K, Regan JW, Yang-Feng TL, Caron MG, Lefkowitz RJ (1990) Expansion of the 2-adrenergic receptor family: cloning and characterization of a human 2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proc Natl Acad Sci USA 87:5094-5098[Abstract/Free Full Text].
• MacDonald E, Kobilka BK, Scheinin M (1997) Gene targetinghoming in on 2-adrenoceptor subtype function. Trends Pharmacol Sci 18:211-219[Medline].
• MacMillan LB, Hein L, Smith MS, Piascik MT, Limbird LE (1996) Central hypotensive effects of the _2a-adrenergic receptor subtype. Science 373:801-803.
• Marjamäki A, Ala-Uotila S, Luomala K, Perälä M, Jansson C, Jalkanen M, Regan JW, Scheinin M (1992) Stable expression of recombinant human 2-adrenoceptor subtypes in two mammalian cell lines: characterization with [³H]rauwolscine binding, inhibition of adenylate cyclase and RNase protection assay. Biochim Biophys Acta 1134:169-177[Medline].
• Marjamäki A, Luomala K, Ala-Uotila S, Scheinin M (1993) Use of recombinant human 2-adrenoceptors to characterize subtype selectivity of antagonist binding. Eur J Pharmacol 246:219-226[ISI][Medline].
• Masse T, Kelly PT (1997) Overexpression of Ca²⁺/calmodulin-dependent protein kinase II in PC12 cells alters cell growth, morphology, and nerve growth factor-induced differentiation. J Neurosci 17:924-931[Abstract/Free Full Text].
• McCune SK, Voigt MM, Hill JM (1993) Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain. Neuroscience 57:143-151[ISI][Medline].
• Milner TA, Rosin DL, Lee A, Aicher SA (1999) Alpha2A-adrenergic receptors are primarily presynaptic heteroreceptors in the C1 area of the rat rostral ventrolateral medulla. Brain Res 821:200-211[ISI][Medline].
• Nicholas AP, Pieribone V, Hökfelt T (1993) Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol 328:575-594[ISI][Medline].
• Nicholas AP, Hökfelt T, Pieribone VA (1996) The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmacol Sci 17:245-255[Medline].
• Okusa MD, Lynch KR, Rosin DL, Huang L, Wei YY (1994) Apical membrane and intracellular distribution of endogenous alpha2A-adrenergic receptors in MDCK cells. Am J Physiol 267:F347-F353[Abstract/Free Full Text].
• Regan JW, Kobilka TS, Yang-Feng TL, Caron MG, Lefkowitz RJ, Kobilka BK (1988) Cloning and expression of human kidney cDNA for an adrenergic receptor subtype. Proc Natl Acad Sci USA 85:6301-6305[Abstract/Free Full Text].
• Rosin DL, Zeng D, Stornetta RL, Norton FR, Riley T, Okusa MD, Guyenet PG, Lynch KRN (1993) Immunohistochemical localization of alpha2A-adrenergic receptors in catecholaminergic and other brainstem neurons in the rat. Neuroscience 56:139-155[ISI][Medline].
• Rosin DL, Talley EM, Lee A, Stornetta RL, Gaylinn BD, Guyenet PG, Lynch KR (1996) Distribution of _2C-adrenergic receptor-like immunoreactivity in the rat central nervous system. J Comp Neurol 372:135-165[ISI][Medline].
• Sallinen J, Link RE, Haapalinna A, Viitamaa T, Kulatunga M, Sjöholm B, MacDonald E, Pelto-Huikko M, Leino T, Barsh GS, Kobilka BK, Scheinin M (1997) Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist. Mol Pharmacol 51:36-46[Abstract/Free Full Text].
• Sallinen J, Haapalinna A, Viitamaa T, Kobilka BK, Scheinin M (1998a) D-Amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically altered expression of the _2C-adrenergic receptor subtype. Neuroscience 86:959-965